ASX Announcements

Securities to be released from Escrow
Release of DARRT-1 Preliminary Safety Data
Pre-Clinical data confirms Radio-Enhancing potential
Noxopharm Corporate Presentation for Public Briefing
End-of-Study Clinical Data shows benefit of NOX66
Noxopharm 2018 Mid-Year Investor Briefings
Section 708 Certificate
Appendix 3B
NOX to present at American Society of Clinical Oncology
Change in substantial holding